UConn Health Case Committee CME

Provided by the UConn School of Medicine and Office of Community and Continuing Medical Education

Purpose: The University of Connecticut School of Medicine, Office of Community and Continuing Medical Education, is now offering a NEW centralized Case Committee CME to our UConn licensed physician faculty/clinicians, affiliated UConn licensed physician faculty/clinicians, APRN’s, and other invitees or learners who actively participates and attend as a member any of our approved departments case conference as listed below who’s meetings are held as “live” sessions. The CME office values the uniqueness of the Case Committee as a learning process in which it addresses the educational content differently than our other more common traditional CME learning activity types, along with the understanding that each member of the Case Committee is indeed an active learner.

Target Audience: UConn Health Department Case/MM committee members, invitees and/or other learners who are Licensed Physician Faculty/Clinicians, or affiliated UConn Health Licensed Physician Faculty/Clinicians, UConn Health residents, fellows, and students.

Program Duration: July 1, 2024, thru June 30, 2027

Learning Objectives: Participants Will (Be Able to):

  • Identify ways to manage complications that occur during patient care.
  • Recognize treat plans for uncommon or unusual diseases and disorders.
  • Identify uncommon presentations of common diseases/disorders.

Activity Director: Melinda Sanders, M, Medical Director for Continuing Medical Education
Co-Activity Director: Christine McNally, MAIOP
Activity Administrator: Kimberly Person, CME Program Administrator

The following is our listing of approved Department or Centers Case/MM Committees under this centralized CME activity:

Carole and Ray Neag Comprehensive Cancer Center / Bone Marrow Transplant Case Committee
Meeting dates: varies, please contact Meg Savage, savage@uchc.edu
Faculty Contact: Kapil Meleveedu, M.D.
Administrative Contact: Meg Savage, RN
Participant link to CME Evaluation Survey: Case Committee CME Evaluation

Department of Nephrology Case Committee
Meeting dates: varies, please contact Brenda Kawecki
Faculty Contact: Srimathi Manickaratnam, M.D.
Administrative Contact: Brenda Kawecki
Participant link to CME Evaluation Survey: Case Committee CME Evaluation

Department of Neurosurgery Case Committee
First Wednesday of each month 6:15‐7:15 a.m.
Third Wednesday of each month 6:30‐7:30 a.m.
Faculty Contact: Ketan Bulsara, M.D.
Administrative Contact: Dina Patel
Participant link to CME Evaluation Survey: Case Committee CME Evaluation

Department of Otolaryngology Case Committee
Meets every 1st Wednesday of each month; WebEx only (please reach out to Administrative Contact for WebEx invite)
Faculty Contact: Danielle Scarola, M.D.
Administrative Contact: Kate Bailey
Participant link to CME Evaluation Survey: Case Committee CME Evaluation

Department of Plasma Cell Case Committee
Meets every 2nd and 4th Thursday of each month, Cancer Center Conference Room
Faculty Contact: Swarup Kumar, M.D., Andrea Moran, APRN
Administrative Contact: Meg Savage, savage@uchc.edu
Participant link to CME Evaluation Survey: Case Committee CME Evaluation

Department of Surgery Case Committee
Meeting Dates/Times/Location: Please reach out Melissa Costa
Faculty Contact: Brian Shames, M.D.
Administrative Contact: Melissa Costa
Participant link to CME Evaluation Survey: Case Committee CME Evaluation

Department of Vascular Case Committee
Meets Every Monday; 12 to 1 p.m.; Outpatient Pavilion, 7th Floor, East Large Conference Room
Faculty Contact: Mina Boutrous, M.D., Laura Grillo, PA-C
Administrative Contact: Melissa Costa
Participant link to CME Evaluation Survey: Case Conference CME Evaluation

*More department Case Committees will be added to this list on an ongoing basis.

Accreditation:  The University of Connecticut School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The University of Connecticut School of Medicine designates this live activity for a maximum of _1.0_ AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Conflict of Interest Policy: All faculty participating in CME activities provided by the University of Connecticut School of Medicine are required to disclose to the program audience any actual or apparent conflict of interest related to the content of their presentations. Program planners have an obligation to resolve any actual conflicts of interest and share with the audience any safeguards put in place to prevent commercial bias from influencing the content.

Disclosure Statements for the Office of Community and Continuing Medical Education:

  • Melinda Sanders, M.D., as activity director and planning member, for this educational event, has no relevant financial relationship(s) with any ineligible companies that could be perceived as a real or apparent conflict of interest in the context of the subject of this presentation that need to be disclosed. All the relevant financial relationships listed for this individual have been mitigated.
  • Christine McNally, MAIOP, as co-activity director and planning member, for this educational event, has no relevant financial relationship(s) with any ineligible companies that could be perceived as a real or apparent conflict of interest in the context of the subject of this presentation that need to be disclosed. All the relevant financial relationships listed for this individual have been mitigated.
  • Kim Person, as activity administrator and planning member, for this educational event, has no relevant financial relationship(s) with any ineligible companies that could be perceived as a real or apparent conflict of interest in the context of the subject of this presentation that need to be disclosed. All the relevant financial relationships listed for this individual have been mitigated.

Disclosure Statements for the Department Planning Member-Facilitators:

  • Swarup Kumar, M.D., as a planning committee member-facilitator, has no relevant financial relationship(s) with any ineligible companies that could be perceived as a real or apparent conflict of interest in the context of the subject of this presentation that need to be disclosed. All the relevant financial relationships listed for this individual have been mitigated.
  • Andrea Moran, APRN, as a planning committee member-facilitator, has no relevant financial relationship(s) with any ineligible companies that could be perceived as a real or apparent conflict of interest in the context of the subject of this presentation that need to be disclosed. All the relevant financial relationships listed for this individual have been mitigated.
  • Meg Savage, APRN, as a planning committee member-facilitator, has no relevant financial relationship(s) with any ineligible companies that could be perceived as a real or apparent conflict of interest in the context of the subject of this presentation that need to be disclosed. All the relevant financial relationships listed for this individual have been mitigated.
  • Mina Bourous, M.D., as a planning committee member-facilitator, has no relevant financial relationship(s) with any ineligible companies that could be perceived as a real or apparent conflict of interest in the context of the subject of this presentation that need to be disclosed. All the relevant financial relationships listed for this individual have been mitigated.
  • Laura Grillo, PA-C, as a planning committee member-facilitator, has no relevant financial relationship(s) with any ineligible companies that could be perceived as a real or apparent conflict of interest in the context of the subject of this presentation that need to be disclosed. All the relevant financial relationships listed for this individual have been mitigated.
  • Melissa Costa, as a planning committee member-facilitator, has no relevant financial relationship(s) with any ineligible companies that could be perceived as a real or apparent conflict of interest in the context of the subject of this presentation that need to be disclosed. All the relevant financial relationships listed for this individual have been mitigated.
  • Danielle Scarola, M.D., as a planning committee member-facilitator, has no relevant financial relationship(s) with any ineligible companies that could be perceived as a real or apparent conflict of interest in the context of the subject of this presentation that need to be disclosed. All the relevant financial relationships listed for this individual have been mitigated.
  • Kate Bailey, as a planning committee member-facilitator, has no relevant financial relationship(s) with any ineligible companies that could be perceived as a real or apparent conflict of interest in the context of the subject of this presentation that need to be disclosed. All the relevant financial relationships listed for this individual have been mitigated.
  • Ketan Bulsara, M.D., as a planning committee member-facilitator, has no relevant financial relationship(s) with any ineligible companies that could be perceived as a real or apparent conflict of interest in the context of the subject of this presentation that need to be disclosed. All the relevant financial relationships listed for this individual have been mitigated.
  • Dina Patel, as a planning committee member-facilitator, has no relevant financial relationship(s) with any ineligible companies that could be perceived as a real or apparent conflict of interest in the context of the subject of this presentation that need to be disclosed. All the relevant financial relationships listed for this individual have been mitigated.
  • Brian Shames, M.D., as a planning committee member-facilitator, has no relevant financial relationship(s) with any ineligible companies that could be perceived as a real or apparent conflict of interest in the context of the subject of this presentation that need to be disclosed. All the relevant financial relationships listed for this individual have been mitigated.
  • Melissa Costa, as a planning committee member-facilitator, has no relevant financial relationship(s) with any ineligible companies that could be perceived as a real or apparent conflict of interest in the context of the subject of this presentation that need to be disclosed. All the relevant financial relationships listed for this individual have been mitigated.
  • Srimathi Manickaratnam, M.D., as a planning committee member-facilitator, has no relevant financial relationship(s) with any ineligible companies that could be perceived as a real or apparent conflict of interest in the context of the subject of this presentation that need to be disclosed. All the relevant financial relationships listed for this individual have been mitigated.
  • Brenda Kawecki, as a planning committee member-facilitator, has no relevant financial relationship(s) with any ineligible companies that could be perceived as a real or apparent conflict of interest in the context of the subject of this presentation that need to be disclosed. All the relevant financial relationships listed for this individual have been mitigated.
  • Kapil Meleveedu, M.D., as a planning committee member-facilitator, has no relevant financial relationship(s) with any ineligible companies that could be perceived as a real or apparent conflict of interest in the context of the subject of this presentation that need to be disclosed. All the relevant financial relationships listed for this individual have been mitigated.
  • Meg Savage, RN, as a planning committee member-facilitator, has no relevant financial relationship(s) with any ineligible companies that could be perceived as a real or apparent conflict of interest in the context of the subject of this presentation that need to be disclosed. All the relevant financial relationships listed for this individual have been mitigated.

This CME activity will not be discussing the use of any off-labeled products or investigational use of any product or device.

Commercial Support Statement: This CME activity has no commercial support associated with it.

Confidentiality: We are committed to protecting your privacy. The information that we collect is for the purpose of awarding CME credits and to evaluate each activity and the educational series as a whole. Other than through the evaluation form, no information is being gathered about people who choose to participate in this program. This is a Case Conference Committee/Morbidity and Mortality document and is confidential in accordance with Section 19a-17b of the Connecticut General Statutes.

Questions: For questions or further information regarding CME for Case Conference sessions, please contact the CME office at cme@uchc.edu.